Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > $RVV $RVVTF - News !

<< Previous

Bullboard Posts

Next >>

Comment by cool888on May 03, 2021 9:48am

93 Views

Post# 33113274

RE:RE:RE:RE:$RVV $RVVTF - News !

peasoupfog wrote:
He means, if they are now going after "severe", it likely means it is working during the trial on "mild and moderate", correct? (With a ?)

1ottrunner wrote: FALSE, there has been no news in regards to the ongoing trial

cool888 wrote:

cool888 wrote: https://www.streetinsider.com/dr/news.php?id=18350600&gfv=1

This is HUGE news ! It means mild to moderate working during trials - correct !

Thanks. U got it my friend !